Kulvinder Singh Saini
Kulvinder Singh Saini
President and CSO
E-mail megerősítve itt: nextgenpharma.com.au - Kezdőlap
Hivatkozott rá
Hivatkozott rá
Production of active eukaryotic proteins through bacterial expression systems: a review of the existing biotechnology strategies
S Sahdev, SK Khattar, KS Saini
Molecular and cellular biochemistry 307 (1), 249-264, 2008
Cell factories for insulin production
NA Baeshen, MN Baeshen, A Sheikh, RS Bora, MMM Ahmed, ...
Microbial cell factories 13 (1), 1-9, 2014
Production of biopharmaceuticals in E. coli: current scenario and future perspectives
MN Baeshen, AM Al-Hejin, RS Bora, MMM Ahmed, HAI Ramadan, ...
Journal of microbiology and biotechnology 25 (7), 953-962, 2015
Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic ß cell line, INS‐1
KS Saini, C Thompson, CM Winterford, NI Walker, DP Cameron
IUBMB Life 39 (6), 1229-1236, 1996
The structure, metabolism and function of the carcinoembryonic antigen gene family
P Thomas, CA Toth, KS Saini, JM Jessup, G Steele Jr
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1032 (2-3), 177-189, 1990
RNA interference therapeutics for cancer: challenges and opportunities
RS Bora, D Gupta, TKS Mukkur, KS Saini
Molecular medicine reports 6 (1), 9-15, 2012
Molecular analysis of PTEN and MXI1 in primary bladder carcinoma
DS Wang, K Rieger‐Christ, JM Latini, A Moinzadeh, J Stoffel, JA Pezza, ...
International Journal of Cancer 88 (4), 620-625, 2000
Amplification of GC-rich genes by following a combination strategy of primer design, enhancers and modified PCR cycle conditions
S Sahdev, S Saini, P Tiwari, S Saxena, KS Saini
Molecular and cellular probes 21 (4), 303-307, 2007
Novel advances in cytochrome P450 research
D Singh, A Kashyap, RV Pandey, KS Saini
Drug discovery today 16 (17-18), 793-799, 2011
Elevated Expression of pp60c-src in Low Grade Human Bladder Carcinomas
P Fanning, K Bulovas, KS Saini, JA Libertino, AD Joyce, IC Summerhayes
Cancer research 52 (6), 1457-1462, 1992
Cytochrome P450s in the development of target-based anticancer drugs
K Purnapatre, SK Khattar, KS Saini
Cancer letters 259 (1), 1-15, 2008
Biochemical and molecular mechanisms regulating apoptosis
KS Saini, NI Walker
Molecular and cellular biochemistry 178 (1), 9-25, 1998
Ciprofloxacin-resistant neisseria meningitidis, Delhi, India
S Singhal, KP Purnapatre, V Kalia, S Dube, D Nair, M Deb, P Aggarwal, ...
Emerging infectious diseases 13 (10), 1614, 2007
Screening of human bladder tumors and urine sediments for the presence of H‐ras mutations
P Levesque, N Ramchurren, K Saini, A Joyce, J Libertino, ...
International journal of cancer 55 (5), 785-790, 1993
Molecular events regulating messenger RNA stability in eukaryotes
KS Saini, IC Summerhayes, P Thomas
Molecular and Cellular Biochemistry 96 (1), 15-23, 1990
Therapeutic role of Ricinus communis L. and its bioactive compounds in disease prevention and treatment
WM Abdul, NH Hajrah, JSM Sabir, SM Al-Garni, MJ Sabir, SA Kabli, ...
Asian pacific journal of tropical medicine 11 (3), 177, 2018
Cancer stem cells: a challenging paradigm for designing targeted drug therapies
IN Khan, S Al-Karim, RS Bora, AG Chaudhary, KS Saini
Drug discovery today 20 (10), 1205-1216, 2015
Dictyostelium discoideum—a promising expression system for the production of eukaryotic proteins
R Arya, A Bhattacharya, KS Saini
The FASEB Journal 22 (12), 4055-4066, 2008
Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
W Iqbal, S Alkarim, A AlHejin, H Mukhtar, KS Saini
Oncotarget 7 (46), 76337, 2016
Mode of action of ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes
V Kalia, R Miglani, KP Purnapatre, T Mathur, S Singhal, S Khan, SR Voleti, ...
Antimicrobial agents and chemotherapy 53 (4), 1427-1433, 2009
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20